About Hemophagocytic Lymphohistiocystosis
The exact cause of hemophagocytic lymphohistiocystosis is not fully understood, but it can be triggered by various factors.
Causes of hemophagocytic lymphohistiocystosis:
- In most cases, HLH is caused by an overactive immune system response to an infection, such as a viral or bacterial infection. The immune system becomes overstimulated and starts attacking healthy cells and tissues in the body.
- In some cases, HLH can be inherited, meaning it is passed down from parents to their children. This is known as familial or primary HLH. It is caused by genetic mutations that affect the immune system's ability to regulate inflammation.
Non-modifiable risk factors of hemophagocytic lymphohistiocystosis are factors that cannot be changed or controlled. These include:
- Age: HLH can occur at any age, but it is more common in children, especially infants.
- Family history: Having a family history of HLH increases the risk of developing the disorder, especially in cases of familial or primary HLH.
Modifiable risk factors of hemophagocytic lymphohistiocystosis are factors that can be influenced or changed. These include:
- Certain infections: Some viral infections, such as Epstein-Barr virus (EBV), cytomegalovirus (CMV), and HIV, have been associated with an increased risk of developing HLH.
- Autoimmune disorders: People with autoimmune disorders, such as rheumatoid arthritis or lupus, may have a higher risk of developing HLH.
- Certain medications: Some medications used to treat autoimmune disorders or cancer can increase the risk of developing HLH.
It's important to note that having these risk factors does not necessarily mean that a person will develop HLH. These factors simply increase the likelihood of developing the condition. If you have concerns about your risk for HLH, it's best to speak with your healthcare provider for personalized advice and guidance.
The most common early symptoms of hemophagocytic lymphohistiocystosis (HLH) include fever and splenomegaly, which is the enlargement of the spleen. These symptoms are often accompanied by other signs such as fatigue, weakness, and pale skin.
As HLH progresses or becomes more severe, additional symptoms may occur. These can vary depending on the individual and the specific stage of the disease. Common symptoms that may occur with later stages of HLH include:
- Cytopenias: This refers to a decrease in the number of blood cells, such as red blood cells, white blood cells, and platelets. It can lead to anemia, increased risk of infections, and easy bruising or bleeding.
- Hepatomegaly: This is the enlargement of the liver. It can cause abdominal pain or discomfort, jaundice (yellowing of the skin and eyes), and abnormal liver function tests.
- Lymphadenopathy: This is the enlargement of lymph nodes. It may cause swelling or lumps in the neck, armpits, or groin.
- Neurological symptoms: In some cases, HLH can affect the nervous system. Symptoms may include headaches, seizures, changes in behavior or personality, weakness, or difficulty speaking.
- Skin rashes: Some individuals with HLH may develop skin rashes or lesions. These can vary in appearance and may be itchy or painful.
It's important to note that these symptoms can also be associated with other conditions, so it's essential to consult a healthcare professional for an accurate diagnosis if you are experiencing any concerning symptoms.
To diagnose HLH healthcare providers commonly perform the following examinations, tests, and procedures:
- Physical exam: During the physical exam, the healthcare provider will look for signs of HLH, such as an enlarged spleen or liver, swollen lymph nodes, skin rashes, or unusual bruising.
- Lab tests: Lab tests are commonly ordered to check a sample of blood, urine, or body tissues. The specific tests depend on the symptoms and conditions being evaluated. Lab findings that may be associated with HLH include low antibody levels, high liver enzyme levels, fever, high triglycerides (blood fats), low albumin (a blood protein), high ferritin levels (iron storage protein) and reduced natural killer cell activity.
- Genetic tests: Genetic tests use samples of blood, saliva, or other tissues to help identify changes in genes, chromosomes, or proteins. These tests can confirm or rule out a suspected genetic disease like familial HLH.
In addition to these common diagnostic procedures, there are additional examinations, tests, and procedures that can be used to assess the severity of HLH and monitor for complications:
- Imaging studies: Diagnostic imaging studies allow doctors to look inside the body to help diagnose or manage a disease. The type of imaging study chosen depends on the patient's symptoms and the part of the body being examined. Common imaging studies for HLH may include X-rays or MRI (magnetic resonance imaging) scans, often used to check for complications such as an enlarged spleen or liver.
- Clinical procedures: In some cases, clinical procedures may be performed to assess symptoms and organ involvement specific to HLH. These procedures can be performed by various healthcare providers such as nurses, physician's assistants, and lab technicians. The results of these procedures are then reviewed by the doctor.
It's important to follow up with your healthcare provider if any symptoms worsen or change after the first physical exam. They will guide you through the diagnostic process and recommend appropriate examinations and tests based on your specific situation.
The goals of treatment for hemophagocytic lymphohistiocystosis (HLH) are to control the overactive immune response, suppress inflammation, and prevent organ damage.
Medication types:
- Etoposide and dexamethasone: These are the first-line medications used to treat HLH. Etoposide helps to suppress the overactive immune response, while dexamethasone reduces inflammation in the body.
- Anakinra: Anakinra is a medication that has shown effectiveness in controlling HLH of various causes. It helps to block a specific protein called interleukin-1, which is involved in the immune response.
- Alemtuzumab: This medication can be used as an alternative regimen for HLH treatment. It targets certain cells of the immune system and helps to reduce their activity.
Therapeutic procedures:
- Intrathecal therapy: This procedure involves delivering medications directly into the spinal fluid through a lumbar puncture, which is a needle inserted into the lower back. It is done for patients with central nervous system (CNS) involvement in HLH.
- Hematopoietic stem cell transplantation (HSCT): HSCT is a procedure where healthy stem cells are transplanted into the body to replace damaged or abnormal cells. It is recommended for patients with an underlying genetic defect or those with persistent or relapsing disease.
Lifestyle behavior changes:
- There are no specific lifestyle behavior changes recommended for HLH treatment. However, it is important for individuals with HLH to follow their healthcare provider's instructions regarding medication instruction, follow-up appointments, and any necessary precautions related to their condition.
Other Treatments:
- In addition to medication and therapeutic procedures, other treatments may be recommended based on the individual's specific situation. These may include supportive care measures such as blood transfusions, antibiotics to treat infections, and management of complications like organ failure.
Each of these treatment options works towards achieving the goals of controlling the overactive immune response, reducing inflammation, and preventing organ damage in HLH. The specific choice of treatment depends on factors such as the underlying cause of HLH, disease severity, and the patient’s unique needs. It is important for individuals with HLH to work closely with their healthcare team to determine the most appropriate treatment plan for their specific needs.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.
Without treatment, HLH can worsen and lead to severe complications.
The natural progression of HLH involves uncontrolled activation of immune cells, such as T lymphocytes and macrophages, along with impaired function of natural killer (NK) cells. This causes an excessive release of cytokines, leading to widespread inflammation. As HLHprogresses, individuals may experience continuous fever, cytopenia (low blood cell counts), splenomegaly (enlarged spleen), hyperferritinemia (high ferritin levels in the blood), coagulopathy (blood clotting problems), and multiorgan failure.
Complications commonly associated with HLH include:
- Infections: Individuals with HLH have an increased risk of developing infections due to the impaired immune response. These infections can further worsen the symptoms and lead to additional complications.
- Organ damage: The excessive inflammation and cytokine release in HLH can cause damage to various organs, including the liver, kidneys, lungs, heart, and central nervous system. This organ damage can result in organ dysfunction or failure.
- Hematologic malignancies: HLH is associated with an increased risk of developing cancers of blood-forming cells, such as leukemia and lymphoma. This further adds to the complexity of the condition and may require additional treatment approaches.
Early diagnosis and prompt treatment are crucial in managing HLH and reducing complications. The goals of treatment for HLH are to control the hyperinflammatory response, eliminate triggers (such as infections or underlying diseases), and restore normal immune function.
Treatment options for HLH typically involve a combination of medications, such as immunosuppressants and chemotherapy agents, to suppress the overactive immune response. In some cases, hematopoietic stem cell transplantation (HSCT) may be recommended to replace abnormal immune cells with healthy ones.
The impact of treatment for HLH can vary depending on various factors, including the individual's overall health, stage of disease progression, and response to treatment. Early intervention and appropriate treatment can help improve outcomes by reducing inflammation, preventing organ damage, and increasing survival rates.
It's important to note that HLH is a complex condition that requires specialized medical care. If you or someone you know is experiencing symptoms suggestive of HLH or has been diagnosed with HLH, it's essential to consult with a healthcare professional for proper evaluation, diagnosis, and management.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.